Schatzberg's Manual of Clinical Psychopharmacology

A seminal resource since the first edition was published in 1986, Schatzberg's
Manual of Clinical Psychopharmacology has distinguished itself, from the very
beginning, for its readability and comprehensive approach to the field. This
tenth edition builds on that legacy, providing a thorough understanding of
evolving treatments and medications. Blending evidence-based information with
practical, real-world experience, this accessible volume examines the efficacy,
dosing, and side effects of drug classes such as antidepressants, antipsychotic
medications, mood stabilizers, and stimulants.

Key features of this
edition include the following: Updated information on newly FDA-approved
agents such as vesicular monoamine transporter type-2 inhibitors for tardive
dyskinesia, as well as those in late-stage review A new chapter on
pharmacogenomic testing and other commercially available tests designed to help
clinicians select appropriate medications for their patients Quick-reference
summary tables on psychotropic classes for swift access to essential
information, facilitating informed decision-making in clinical practice A
comprehensive list of suggested readings for each chapter, opening the door to
further study and exploration

Additional sections also discuss approaches
to treatment-resistant disorders, pharmacotherapy for substance use disorders,
and working in specific settings and with special populations-including
emergency department treatment and treating pregnant patients, children, and
individuals from minority and marginalized communities.

With its
unrivaled wealth of information, Schatzberg's Manual of Clinical
Psychopharmacology remains a trusted, indispensable resource for clinicians
seeking the latest advancements in psychopharmacology, arming them with the
knowledge they will need to navigate with confidence the intricacies of
psychotropic medications.